Sodium channel enhancer restores baroreflex sensitivity in conscious dogs with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Shen, Weiqun ^a   Gill, Robert M ^a   Zhang, Jian Ping ^a   Jones, Bonita D ^a   Corbly, Angela K ^a   Steinberg, Mitchell I ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Bradycardia; Cardiac inotropic response

Indexed keywords

4 [3 [[1 (DIPHENYLMETHYL) 3 AZETIDINYL]OXY] 2 HYDROXYPROPYLAMINO] 1H INDOLE 2 CARBONITRILE MANDELATE; LY 368052; SODIUM CHANNEL; SODIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CHRONOTROPISM; CONTROLLED STUDY; DOG; DOSE RESPONSE; GANGLION BLOCK; HEART FAILURE; HEART PACING; HEART VENTRICLE CONTRACTILITY; INOTROPISM; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AZETIDINES; BAROREFLEX; BLOOD PRESSURE; BRADYCARDIA; CARDIOTONIC AGENTS; CONSCIOUSNESS; DOGS; ELECTROCARDIOGRAPHY; GANGLIONIC BLOCKERS; HEART FAILURE, CONGESTIVE; MALE; MANDELIC ACIDS; RECEPTORS, ADRENERGIC, BETA; SODIUM CHANNELS; VENTRICULAR FUNCTION, LEFT;

EID: 15744380584     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00337.2004     Document Type: Article

References (39)

1. Airaksinen KE, Ylitalo A, Niemela MJ, Tahvanainen KU, and Huikuri HV. Heart rate variability and occurrence of ventricular arrhythmias during balloon occlusion of a major coronary artery. Am J Cordial 83: 1000-1005, 1999.
2. Asai K, Uechi M, Sato N, Shen W, Meguro T, Mathier MA, Shannon RP, and Vatner SF. Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure. Am J Physiol Heart Circ Physiol 275: H2219-H2226, 1998.
3. Baumgart D, Ehring T, Krajcar M, Skyschally A, and Heusch G. Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain. Basic Res Cardiol 89: 61-79, 1994.
4. Bers DM. Mechanisms contributing to the cardiac inotropic effect of Na pump inhibition and reduction of extracellular Na. J Gen Physiol 90: 479-504, 1987.
5. Brandle M, Wang W, and Zucker IH. Hemodynamic correlates of baroreflex impairment of heart rate in experimental canine heart failure. Basic Res Cardiol 91: 147-154, 1996.
6. Brasch H and Iven H. Inotropic and electrophysiological effects of BDF 9148, a congener of DPI 201-106, in guinea-pig atria and papillary muscles. Br J Pharmacol 103: 1939-1945, 1991.
7. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, and Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211, 1982.
8. Buggisch D, Isenberg G, Ravens U, and Scholtysik G. The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated heart preparations. Eur J Pharmacol 118: 303-311, 1985.
9. Doggrell SA, Hoey A, and Brown L. Ion channel modulators as potential positive inotropic compound for treatment of heart failure. Clin Exp Pharmacol Physiol 21: 833-843, 1994.
10. 2+ exchanger in failing human myocardium. Circulation 94: 992-1002, 1996.
11. Gill RM, Jones BD, Steinberg MI, and Shen W. A sodium channel enhancer, LY341311, increases myocardial contractile performance without increasing heart rate in conscious normal dogs. A comparison with dobutamine. J Card Fail 8: 33-42, 2002.
12. Higgins CB, Vatner SF, Eckberg DL, and Braunwald E. Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest 51: 715-724, 1972.
13. Katz A. Potential deleterious effect of inotropic agents in the therapy of chronic heart failure. Circulation 73: 184-190, 1986.
14. Kelly RA and Smith TW. Digoxin in heart failure: implications of recent trials. J Am Coll Cardiol 22: 107A-120A, 1993.
15. Kinugawa T and Dibner-Dunlap ME. Altered vagal and sympathetic control of heart rate in left ventricular dysfunction and heart failure. Am J Physiol Regul Integr Comp Physiol 268: R317-R323, 1995.
16. Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homey CJ, Vatner SF, and Vatner DE. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 91: 907-914, 1993.
17. Komamura K, Shannon RP, Ihara T, Shen YT, Mirsky I, Bishop SP, and Vatner SF. Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol Heart Circ Physiol 265: H1119-H1131, 1993.
18. Kunze DL and Brown AM. Sodium sensitivity of baroreceptors. Reflex effects on blood pressure and fluid volume in the cat. Circ Res 42: 714-720, 1978.
19. McCall E, Crumb W, and Steinberg MI. A comparison of the contractile activities of two sodium channel modulators, LY366634 and LY360852, in isolated cardiac myocytes (Abstract). J Heart Fail 4: A270, 1997.
20. 2+- exchanger in human myocardium. Br J Clin Pharmacol 43: 399-405, 1997.
21. Nand V and Doggrell SA. Effects of BDF 9148 on the action potentials and contractions of left ventricles from normo- and hypertensive rats. Clin Exp Pharmacol Physiol 26: 212-219, 1999.
22. Niebauer MJ, Holmberg MJ, and Zucker IH. Aortic baroreceptor characteristics in dogs with chronic high output failure. Basic Res Cardiol 81: 111-122, 1986.
23. Osterziel KJ, Hanlein D, Willenbrock R, Eichhorn C, Luft F, and Dietz R. Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 73: 517-522, 1995.
24. Raap A, Armah B, Mest HJ, Stenzel W, Schloos J, and Blechacz W. Investigations of the mechanism of the positive inotropic action of BDF 9148; comparison with DPI 201-106 and the enantiomers. J Cardiovasc Pharmacol 29: 164-173, 1997.
25. ca) by the enantiomers of DPI 201-106 and BDF 8784. Br J Pharmacol 104: 490-494, 1991.
26. + channels as sites of action of the cardiotonic agent DPI 201-106 with agonist and antagonist enantiomers. Proc Natl Acad Sci USA 84: 896-900, 1987.
27. +-channel activation as a positive inotropic principle. J Cardiovasc Pharmacol 14: S24-S29, 1989.
28. Scholtysik G, Salzmann R, Berthold R, Herzig U, Quast U, and Markstein R. DPI 201-106, a novel cardiotonic agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol 329: 316-325, 1985.
29. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, and Ingwall JS. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs. A compensatory role for the parallel loss of creatine. Circulation 100: 2113-2118, 1999.
30. Shen W, Gill RM, Jones BD, Zhang JP, Corbly AK, and Steinberg MI. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine. J Pharmacol Exp Ther 303: 673-680, 2002.
31. Shen W, Xu X, Ochoa M, Zeballos GA, Stewart JM, and Hintze TH. Contribution of the ventricules and the atrial appendages to the elevation of plasma atrial natriuretic factor (ANF) during pacing-induced heart failure in conscious dogs. Basic Res Cardiol 91: 319-328, 1996.
32. Steinberg MI, McCall E, Mest HJ, Raap A, and Wright T. Cardiac sodium channels: a new target for inotropic agents. Heart Fail Rev 2: 173-193, 1998.
33. Stewart JM, Patel MB, Wang J, Ochoa M, Gewitz M, Loud AV, Anversa P. and Hintze TH. Chronic elevation of norepinephrine in conscious dogs produces hypertrophy with no loss of LV reserve. Am J Physiol Heart Circ Physiol 262: H331-H339, 1992.
34. Taniumra M, Mishima T, Steinberg MI, Borzak S, Goldstein S, and Sabbah HN. Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure. Cardiovasc Drugs Ther 14: 77-82, 2000.
35. Tuininga YS, van Veldhuisen DJ, Brouwer J, Haaksma J, Crijns HJ, Man in't Veld AJ, and Lie KI. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. Br Heart J 72: 509-513, 1994.
36. Uechi M, Asai K, Sato N, and Vatner S. Voltage-dependent calcium channel promoter restores baroreflex sensitivity in conscious dogs with heart failure. Circulation 98: 1342-1347, 1998.
37. Vatner SF, Higgins CB, and Braunwald E. Sympathetic and parasympathetic components of reflex tachycardia induced by hypotension in conscious dogs with and without heart failure. Cardiovasc Res 8: 153-161, 1974.
38. Wang W, Chen JS, and Zucker IH. Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ Res 68: 1294-1301, 1991.
39. Zucker IH, Wang W, Brandle M, Schultz HD, and Patel KP. Neural regulation of sympathetic nerve activity in heart failure. Prog Cardiovasc Dis 37: 397-414, 1995.